Holen Sie sich die Stockscreener-App
38.63
1.74%
0.66
Handel nachbörslich:
38.63
Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten
Castle Biosciences (CSTL) Highlights Breakthrough in Barrett's E - GuruFocus
Castle Biosciences Announces Publication of Study Confirming TissueCypher® Test's Efficacy in Risk Stratification for Barrett's Esophagus Patients - Quiver Quantitative
Systematic Review and Meta-Analysis Confirms TissueCypher® - GlobeNewswire
Expert Melanoma Panel Recommends Castle Biosciences DecisionDx-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma - marketscreener.com
Castle Biosciences Announces Endorsement of DecisionDx-Melanoma Test in Independent Expert Consensus Paper - Quiver Quantitative
Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma - Yahoo Finance
Castle Biosciences (NASDAQ:CSTL) Insider Sells $53,600.17 in Stock - MarketBeat
Here's Why 'Trend' Investors Would Love Betting on Castle Biosciences (CSTL) - Yahoo Finance
New York State Common Retirement Fund Acquires 52,671 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Purchased by Schroder Investment Management Group - MarketBeat
Will Castle Biosciences Inc. stock attract more institutional investorsFed Meeting & Reliable Price Breakout Signals - Newser
XTX Topco Ltd Increases Stock Holdings in Castle Biosciences, Inc. $CSTL - MarketBeat
Geode Capital Management LLC Boosts Stake in Castle Biosciences, Inc. $CSTL - MarketBeat
8,362 Shares in Castle Biosciences, Inc. $CSTL Purchased by Elevation Point Wealth Partners LLC - MarketBeat
Castle Biosciences stock hits 52-week high at 40.61 USD By Investing.com - Investing.com Australia
Castle Biosciences stock hits 52-week high at 40.61 USD - Investing.com
Summit Global Investments Lowers Stake in Castle Biosciences, Inc. $CSTL - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Grows Stock Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Derek Maetzold Sells 5,115 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Is Castle Biosciences Inc. stock a buy before product launches2025 Analyst Calls & Fast Entry Momentum Trade Alerts - BỘ NỘI VỤ
Castle Biosciences (NASDAQ:CSTL) Hits New 52-Week HighTime to Buy? - MarketBeat
CSTL Form 4: CEO stock sale and updated insider holdings - Stock Titan
Castle Biosciences (NASDAQ:CSTL) Insider Tobin Juvenal Sells 4,693 Shares - MarketBeat
CEO Maetzold Files To Sell 10,712 Of Castle Biosciences Inc [CSTL] - TradingView
How Much Upside is Left in Castle Biosciences (CSTL)? Wall Street Analysts Think 50.08% - MSN
Castle Biosciences Executive Sells Shares - TradingView
Officer Juvenal Sells 4,693 ($167K) Of Castle Biosciences Inc [CSTL] - TradingView
[Form 4] CASTLE BIOSCIENCES INC Insider Trading Activity - Stock Titan
Top 5 Articles of the Week: November 16-21 - Dermatology Times
Is Pune Es Valuation Cheap Compared to Growth PeersChart Pattern Recognition & Superior Wealth Building - earlytimes.in
Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Castle Biosciences partners with SciBase for diagnostic tests - MSN
What Makes Castle Biosciences (CSTL) a New Strong Buy Stock - MSN
Castle Biosciences, Inc. (086.F) stock price, news, quote and history - Yahoo Finance UK
Castle Biosciences (NASDAQ:CSTL) Sets New 1-Year HighTime to Buy? - MarketBeat
Castle Biosciences stock hits 52-week high at $35.68 By Investing.com - Investing.com Canada
Castle Biosciences stock hits 52-week high at $35.68 - Investing.com
Can Castle Biosciences Inc. stock deliver consistent earnings growthJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
Castle Biosciences earns Houston Top Workplace title for fifth year - Traders Union
Castle Biosciences (CSTL): Evaluating Valuation as New Melanoma Test Data Gains Attention at Major Oncology Congress - Yahoo Finance
Castle Biosciences, Inc. (CSTL) Reports Next Week: Wall Street Expects Earnings Growth - MSN
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Castle Biosciences, Inc. (CSTL) Competitors - Meyka
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year - The Manila Times
Zacks.com featured highlights include Perimeter Solutions, Interface, Castle Biosciences and Great Lakes Dredge & Dock - sharewise.com
Castle Biosciences, Inc. $CSTL Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Will Castle Biosciences Inc. stock remain a Wall Street favorite2025 Volatility Report & Reliable Trade Execution Plans - newser.com
Castle Biosciences Inc. recovery potential after sell off2025 Biggest Moves & AI Driven Stock Reports - newser.com
Advisors Capital Management LLC Purchases 44,180 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Full technical analysis of Castle Biosciences Inc. stockEarnings Miss & Breakout Confirmation Alerts - newser.com
Is Castle Biosciences Inc. stock a dividend growth opportunity2025 Buyback Activity & Fast Gain Stock Trading Tips - newser.com
1.15%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):